Effect of food containing algae intake on metabolic syndrome related factor
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000043114
- Lead Sponsor
- Medical Corporation Hokubukai Utsukushigaoka hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Not provided
1)At least one previous medical history of malignant tumor, heart failure or myocardial infraction 2) Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus. 3) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). 4)Subjects who excessive alcohol intake. 5)Subjects who are allergic to medicines and/or the test food related products. 6)Subjects who took part in another clinical study within 3 months prior to the start of the present study. 7)Subjects who routinely intake supplements such as euglena, chlorella, spirulina, beta-glucan and supplement that may decrease the visceral fat level, cholesterol and blood sugar level. 8) Subjects are taking warfarin and the investigator has determined that it is inappropriate for this study. 9)Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 10)Subjects with abnormal food habit or irregular life style such as shifts workers or late-night workers. 11) Subjects who suffer from severe anemia 12)Subjects having blood sample 400mL or more taken within 3 months prior to the start of the present study (e.g. donated blood). 13)Subjects have some designed infectious disease. 14) Subjects deemed unsuitable by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visceral fat area, body fat percentage, HDL-cholesterol, triglyceride, fasting blood sugar, waist circumference, systolic blood pressure, diastolic blood pressure, LDL-cholesterol
- Secondary Outcome Measures
Name Time Method 1)Subcutaneous fat area, total fat area, weight 2)adiponectin, leptin, free fatty acids, Insulin, HOMA-R, HbA1c, Total cholesterol 3)Immunoglobulin, anti-paramylon antibody titer 4) questionnaire survey about physical condition, defecation behavior, eating behavior, exercise behavior